Skip to main content

CORRECTION article

Front. Pharmacol.
Sec. Obstetric and Pediatric Pharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1444228

Corrigendum: Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept

Provisionally accepted
  • Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands

The final, formatted version of the article will be published soon.

    Keywords: Anti-thymocyte globulin (ATG), TDM (therapeutic drug monitoring), Stem cell transplant (SCT), antibody, pediatrics-children

    Received: 05 Jun 2024; Accepted: 28 Jun 2024.

    Copyright: © 2024 Admiraal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Rick Admiraal, Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.